21. Engineering T Cell Receptors to Target H3.3G34 Mutant Glioblastoma. (16th November 2020) Authors: Wang, Anthony C; Owens, Geoffrey; Lee, Alexander; Sun, Matthew Z; Peeters, Sophie; Kienzler, Jenny C; Orpilla, Joey; Contreras, Erick; Treger, Janet; Odesa, Sylvia K; Everson, Richard G; Holland, Eric C; Becher, Oren; Nathanson, David; Xing, Yi; Liau, Linda M; Prins, Robert M Journal: Neurosurgery Issue: Volume 67(2010)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. EPCO-10. INTRATUMORAL HETEROGENEITY OF ENVIRONMENT-INDUCED EXPRESSION PROGRAMS IN GLIOMA PATIENTS AND DERIVED MODEL SYSTEMS. (12th November 2021) Authors: Bayley, Nicholas; Tse, Christopher; Zhu, Henan; Ta, Lisa; Baufeld, Lynn; Gosa, Laura; Yan, Weihong; Prins, Robert; Yong, William; Cloughesy, Timothy; Liau, Linda; Graeber, Thomas; Nathanson, David Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure. Issue 1 (December 2016) Authors: Nathanson, David; Frick, Mats; Ullman, Bengt; Nyström, Thomas Journal: Diabetology & metabolic syndrome Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden: A population‐based register study. Issue 1 (15th November 2019) Authors: Fahlén Bergh, Cecilia; Toivanen, Susanna; Johnell, Kristina; Calissendorff, Jan; Skov, Jakob; Falhammar, Henrik; Nathanson, David; Lindh, Jonatan D.; Mannheimer, Buster Journal: Pharmacoepidemiology and drug safety Issue: Volume 29:Issue 1(2020) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Issue 8 (24th April 2020) Authors: Wen, Patrick Y; Weller, Michael; Lee, Eudocia Quant; Alexander, Brian M; Barnholtz-Sloan, Jill S; Barthel, Floris P; Batchelor, Tracy T; Bindra, Ranjit S; Chang, Susan M; Chiocca, E Antonio; Cloughesy, Timothy F; DeGroot, John F; Galanis, Evanthia; Gilbert, Mark R; Hegi, Monika E; Horbinski, Crai... Journal: Neuro-oncology Issue: Volume 22:Issue 8(2020) Page Start: 1073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke. Issue 5 (May 2015) Authors: Darsalia, Vladimer; Larsson, Martin; Nathanson, David; Klein, Thomas; Nyström, Thomas; Patrone, Cesare Journal: Journal of cerebral blood flow & metabolism Issue: Volume 35:Issue 5(2015) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. IMMU-02. NEOANTIGENS ARISING FROM ALTERNATIVE SPLICING EVENTS MAY BE TARGETED BY TUMOR INFILTRATING LYMPHOCYTES IN GLIOBLASTOMAS. (11th November 2019) Authors: Lee, Alexander; Pan, Yang; Mochizuki, Aaron; Galvez, Mildred; Chow, Frances; Nathanson, David; Wang, Anthony; Everson, Richard; Liau, Linda; Xing, Yi; Prins, Robert Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. IMMU-12. ABERRANT EGFR SIGNALING IS ASSOCIATED WITH DIMINISHED CYTOTOXIC T-CELL INFILTRATION IN GLIOBLASTOMA PATIENTS. (14th November 2022) Authors: Pioso, Marissa; Sun, Lu; Bayley, Nicholas; Anil, Amanda; Lee, Alexander; Nathanson, David; Prins, Robert Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. IMMU-20. SINGLE-CELL RNASEQ OF TUMOR INFILTRATING IMMUNE CELLS FROM NEOADJUVANT ANTI-PD1 TREATED GBM PATIENTS REVEALS GLOBAL TRANSCRIPTIONAL CHANGES AND IMMUNOSUPPRESSIVE ADAPTIVE RESPONSES BY MYELOID CELLS. (9th November 2020) Authors: Lee, Alexander; Mochizuki, Aaron; Chow, Frances; Reynoso, Jeremy; Orpilla, Joey; Sun, Lu; Chavez, Carolina; Galvez, Mildred; Kienzler, Jenny; Yong, William; Everson, Richard; Nathanson, David; Bensinger, Steven; Liau, Linda; Cloughesy, Timothy; Hugo, Willy; Prins, Robert Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. IMMU-41. NEOADJUVANT PD-1 BLOCKADE INDUCES T CELL AND CDC1 ACTIVATION BUT FAILS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR ASSOCIATED MACROPHAGES IN RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Lee, Alexander; Sun, Lu; Mochizuki, Aaron; Reynoso, Jeremy; Orpilla, Joey; Chow, Frances; Kienzler, Jenny; Everson, Richard; Nathanson, David; Liau, Linda; Cloughesy, Timothy; Hugo, Willy; Prins, Robert Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗